AIM
DGX icon

Axiom Investment Management’s Quest Diagnostics DGX Stock Holding History

Axiom Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Hold
50
– – 0.01% 359
2026
Q1 		$9.8K Buy
+50
New +$9.71K 0.01% 323
2019
Q4 		– Sell
-2,588
Closed -$272K – 158
2019
Q3 		$272K Sell
2,588
-8,785
-77% -$902K 0.21% 125
2019
Q2 		$1.16M Buy
11,373
+1,269
+13% +$122K 0.21% 117
2019
Q1 		$929K Buy
+10,104
New +$876K 0.18% 139

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Axiom Investment Management's DGX Position: Q2 2026 in Review

Axiom Investment Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 50 shares worth $10.6K. The position accounts for 0.01% of the portfolio, ranked #359.

Axiom Investment Management first reported a position in DGX in Q1 2019 and has held it in 5 quarters since. The position peaked at $1.16M in Q2 2019. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Axiom Investment Management held 50 shares of Quest Diagnostics worth $10.6K as of Q2 2026.
  • Axiom Investment Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.01% of Axiom Investment Management's portfolio in Q2 2026, its #359 holding.
  • Axiom Investment Management first reported a position in Quest Diagnostics in Q1 2019 and has held it in 5 quarters since.
  • Axiom Investment Management's Quest Diagnostics position peaked at $1.16M in Q2 2019.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.